Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOMAPACITAN-BECO: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

57.1%
Female
42.9%
Male

Age Information

The average age of patients reporting adverse events with SOMAPACITAN-BECO is 34.4 years.

Geographic Distribution

The majority of adverse event reports for SOMAPACITAN-BECO originate from JP.

Report Summary & Outcomes

47
Total Reports
47
As Primary/Secondary Suspect
5
Deaths Reported
15
Hospitalizations
1
Life-Threatening
1
Disabilities

Reporting Timeline

First adverse event report: 20220101. Most recent report: 20250901. View full timeline →

More About SOMAPACITAN-BECO

SOMAPACITAN-BECO Full Profile Reports by Year Drug Interactions